arsenic trioxide has been researched along with Experimental Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazarbachi, A; El Eit, R; Itani, AR; Jabbour, M; Mahon, FX; Nasr, R; Nassar, F; Rasbieh, N; Santina, A; Zaatari, G | 1 |
| Chung, JG; Huang, WW; Kuo, SC; Lai, IC; Lai, TY; Lin, CC; Lin, JJ; Wen, YF; Yang, JS | 1 |
| Blusztajn, A; Kenific, C; Ren, R; Shackelford, D; Waxman, S | 1 |
| Chen, GQ; Chen, Z; Jing, Y; Miller, WH; Wang, L; Waxman, S; Xia, L | 1 |
4 other study(ies) available for arsenic trioxide and Experimental Leukemia
| Article | Year |
|---|---|
Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Autophagy; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hedgehog Proteins; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice, Inbred BALB C; Mice, Transgenic; Protein Kinase Inhibitors | 2019 |
Arsenic trioxide (As₂O₃) inhibits murine WEHI-3 leukemia in BALB/c mice in vivo.
Topics: Animals; Antigens, Differentiation; Arsenic Trioxide; Arsenicals; B-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Leukemia; Leukemia, Experimental; Macrophages; Male; Mice; Mice, Inbred BALB C; Oxides; Spleen; Tretinoin | 2012 |
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Core Binding Factor Alpha 2 Subunit; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Leukemia, Experimental; Male; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Oncogene Proteins, Fusion; Oxides; Proteasome Endopeptidase Complex; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Survival Analysis; Transfection; Ubiquitin | 2006 |
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Northern; Blotting, Western; Cell Culture Techniques; Cell Differentiation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance; Female; Humans; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, SCID; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Survival Rate; Tretinoin | 2001 |